Covid-19 effect on ER: Who wins and who loses?

So, we're more than 2 months into this pandemic. Anyone have any insight into how this is going to change the equity research industry?

Will panicked investors return to active management, lifting all boats? Will BBs take more share and walk away winners? Will declining AUMs devastate the entire industry?

Has anyones' department already announced hiring freezes, layoffs, or bonus reductions? If so, what type of firm are you at (MM/EB/B/BB)?

I'm an incoming associate, and I'm just trying to gauge how much of shit show I'm entering.

Region
9 Comments
 

Interesting questions, would love to know also. It's a shame that the ER part of the forum is so dead

 

I honestly think this is TBD. More dynamic environments like this give the sell side a lot of ammo to add value and help the buyside digest what’s happening. However, I don’t think this will necessarily stop the shrinking wallet and other headwinds. If economic damage/markets end up a lot worse and causes more hedge funds to shut down or people to pull funds from shops, it would be bad also obviously.

My firm has not had COVID related layoffs in ER. I don’t expect the bonus environment (already not great) to change much as a result at this point, but who knows

 
Most Helpful

Eum consequatur enim nam temporibus iure quia libero quibusdam. Nostrum dolorum nihil porro asperiores ad atque voluptatem. Optio ea amet excepturi impedit perferendis enim aliquam est. Earum blanditiis vitae ea. Assumenda aut consequatur et. Suscipit sit suscipit nostrum porro. Maiores itaque et sunt itaque.

Ducimus in rerum modi necessitatibus ut et. Accusamus beatae voluptas aliquam. Ipsam soluta nihil molestiae cum blanditiis quo. Rerum ratione autem similique ipsa maxime.

Minus minus perferendis libero sunt rem. Quos nesciunt et et quos ullam molestias ipsam. Odit quibusdam quia sapiente. Ea dolor dolor praesentium et pariatur porro sunt adipisci.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (78) $151
  • Intern/Summer Analyst (72) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”